Topics
Gliomas | Overall management | Overview
Home > Publications > Topics > Gliomas > Overall management > Overview
No
authors listed.
Glioma.
Nat
Rev Dis Primers.
2024 May 9;10(1):34. doi:
10.1038/s41572-024-00524-y. PMID:
38724549. Primer. ˍ
Weller M, Wen PY, Chang SM, Dirven L, Lim M, Monje M, Reifenberger
G.
Glioma.
Nat
Rev Dis Primers. 2024 May 9;10(1):33. doi:
10.1038/s41572-024-00516-y. PMID:
38724526. Review˰
ˍ
*Lerner A, Palmer K, Campion T, Millner TO, Scott E, Lorimer C,
Paraskevopoulos D, McKenna G, Marino S, Lewis R, Plowman
N.
Gliomas in adults: Guidance on
Investigations, Diagnosis, Treatment & Surveillance.
Clin
Med (Lond). 2024 Sep 2:100240. doi:
10.1016/j.clinme.2024.100240. PMID:
39233205. Review. ˍ
Peters KB, Geurts M.
Practical
management of patients with IDH-mutant glioma
in the coming era of mIDH inhibitors:
New drugs, new evidence, new guidelines,
and new considerations.
Neurooncol
Pract. 2024 Oct 19;12(Suppl 1):i2-i5. doi:
10.1093/nop/npae076. PMID:
39776529. Review. ˍ
Westphal M, Drexler R, Maire C, Ricklefs F, Lamszus K.
Cancer
neuroscience and glioma: clinical implications.
Acta
Neurochir (Wien). 2025 Jan 3;167(1):2. doi:
10.1007/s00701-024-06406-2. PMID:
39752006. Review. ˍ